Prevention of Venous Thromboembolism after Stroke

Topics in Stroke Rehabilitation

Volumn 10, Issue 3, 2003, Pages 61-69

  Harvey, Richard L ^a  

^a REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

Anticoagulants; Cerebrovascular accident; Heparin; Platelet inhibitors; Pulmonary embolism; Rehabilitation; Venous thrombosis; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARDEPARIN; BIOCHEMICAL MARKER; DALTEPARIN; DANAPAROID; ENOXAPARIN; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BED REST; BLEEDING; BLOOD CLOTTING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DEVICE; DRUG EFFICACY; DRUG SAFETY; ELECTROSTIMULATION; FIBRINOLYTIC THERAPY; HEMIPLEGIA; HUMAN; IMMOBILIZATION; INCIDENCE; LOW DRUG DOSE; LUNG EMBOLISM; META ANALYSIS; MOBILIZATION; MORBIDITY; MORTALITY; PARALYSIS; PATIENT CARE; REVIEW; RISK FACTOR; STROKE; THROMBOEMBOLISM; THROMBOGENICITY; VEIN BLOOD FLOW; VEIN THROMBOSIS;

ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; PLATELET AGGREGATION INHIBITORS; PRESSURE; PULMONARY EMBOLISM; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0344064076     PISSN: 10749357     EISSN: None     Source Type: Journal    
DOI: 10.1310/54NU-U4CP-5KC8-JM9W     Document Type: Review

References (50)

1. Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: literature review and implications for clinical practice. Arch Phys Med Rehabil. 1992;73:S379-S391.
2. McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Aging. 1986;15:84-88.
3. McCarthy ST, Turner JJ, Robertson D, Hawkey CJ. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet. 1977;11:800-801.
4. Gelmers HJ. Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke. Acta Neurol Scand. 1980;61:313-318.
5. Turpie AGG, Hirsh J, Jay RM, et al. Double-blind randomised trial of ORG 10172 low-molecular weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet. 1987;1:523-526.
6. Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJH. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis. 1989;19:245-250.
7. Elias A, Milandre L, Langrange G, et al. Prévention des thromboses veineuses profondes des membres inferieurs par une fraction d'héparine de très bas poids moléculaire (CY222) chez des patients porteurs d'une hémiplégie secondaire à un infarctus cérébral: étude pilote randomisée (30 patients). Rev Med Interne. 1990;11:95-98.
8. Sandset PM, Dahl MS, Stiris M, Rostad B, Scheel B, Abildgaard U. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Semin Thromb Hemost. 1990;16:25-33.
9. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 1981;12:474-477.
10. Brown M, Glassenberg M. Mortality factors in patients with acute stroke. JAMA. 1973;224:1493-1495.
11. Viitanen M, Winblad B, Asplund K. Autopsy verified causes of death after stroke. Acta Medica Scand. 1987;222:401-408.
12. Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc. 1997;72:297-300.
13. Cope C, Reyes TM, Skversky NJ. Phlebographic analysis of the incidence of thrombosis in hemiplegia. Radiology. 1973;109:581-584.
14. Miyamoto AT, Miller LS. Pulmonary embolism in stroke: prevention by early heparinization of venous thrombosis detected by Iodine-125 fibrinogen leg scans. Arch Phys Med Rehabil. 1980;61:584-587.
15. Sioson ER, Crowe WE, Dawson NV. Occult proximal deep vein thrombosis: its prevalence among patients admitted to a rehabilitation hospital. Arch Phys Med Rehabil. 1988;69:183-185.
16. Pambianco G, Orchard T, Landau P. Deep vein thrombosis: prevention in stroke patients during rehabilitation. Arch Phys Med Rehabil. 1995;76:324-330.
17. Oczkowski WJ, Ginsberg JS, Shin A, Panju A. Venous thromboembolism in patients undergoing rehabilitation for stroke. Arch Phys Med Rehabil. 1992;73:712-716.
18. Harvey RL, Roth EJ, Yarnold PR, Durham JR, Green D. Deep vein thrombosis in stroke: the use of plasma D-dimer level as a screening test in the rehabilitation setting. Stroke. 1996;27:1516-1520.
19. Bromfield EB, Reding MJ. Relative risk of deep venous thrombosis or pulmonary embolism post-stroke based on ambulatory status. J Neuro Rehabil. 1988;2:51-57.
20. Rosenberg RD, Bauer KA. Does a prethrombotic state exist? If so, what is it? Am J Clin Nutr. 1992;56:787S-788S.
21. Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative aging study. J Clin Invest. 1987;80:1527-1534.
22. Sorensen JV, Jensen HP, Rahr HB, et al. Haemostatic activation in patients with head injury with and without simultaneous multiple trauma. Scand J Clin Lab Invest. 1993;53:659-665.
23. Desmukh M, Bisignani M, Landau P, Orchard TJ. Deep vein thrombosis in rehabilitating stroke patients. Incidence, risk factors and prophylaxis. Am J Phys Med Rehabil. 1991;70:313-316.
24. Skillman JJ, Collins RE, Coe MP, et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery. 1978;83:354-358.
25. Turpie AGG, Gallus AS, Beattie WS, Hirsh J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology. 1977;27:435-438.
26. Prasad BK, Banerjee AK, Howard H. Incidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics. Age Aging. 1982;11:42-44.
27. Kamran S, Downey D, Ruff R. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology. 1998;50:1683-1688.
28. Green D, Akuthota V, Eiken M, et al. Prevention of thromboembolism in stroke rehabilitation patients. Top Stroke Rehabil. 1998;5(2):68-74.
29. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Q J Med. 2000;93:359-364.
30. International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-1581.
31. Chinese Acute Stroke Trial Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:1641-1649.
32. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
33. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
34. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
35. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ. 1994;308:235-246.
36. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet. 2000;355:1295-1302.
37. Gubitz G, Sandercock P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. The Cochrane Library. 1999;4:Update Software.
38. Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke. The Cochrane Library. 2002;1:Update Software.
39. Turpie AGG, Gent M, Cote R, et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med. 1992;117:353-357.
40. Dumas R, Woitinas F, Kutnowski M, et al. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age Aging. 1994;23:512-516.
41. Hillbom M, Erila T, Sotaniemi K, Tatlisumak T, Sarna S, Kaste M. Enoxaparin vs. heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double blind study. Acta Neurol Scand. 2002;106:84-92.
42. TOAST Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA. 1998;279:1265-1272.
43. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention atrial fibrillation II study. Lancet. 1994;343:687-691.
44. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomized clinical trial. Lancet. 1996;348:633-638.
45. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AGG. Antithrombotic therapy in patients with mechanical and prosthetic heart valves. Chest. 2001;119:220S-227S.
46. Lip GYH, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J. 1995;73:527-533.
47. Prystowsky EN, Benson DW, Fuster V, et al. Management of patients with atrial fibrillation. A statement for the healthcare professionals from the subcommittee on electrocardiography and electrophysiology. American Heart Association. Circulation. 1996;93:1262-1277.
48. Koefoed BG, Petersen P. Oral anticoagulation in nonvalvular atrial fibrillation. J Intern Med. 1999;245:375-381.
49. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-175S.
50. Dahan R, Houlbert D, Caulin C, et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial. Haemostasis. 1986;16:159-164.